IE34877B1 - Triazine-derivatives - Google Patents

Triazine-derivatives

Info

Publication number
IE34877B1
IE34877B1 IE421/70A IE42170A IE34877B1 IE 34877 B1 IE34877 B1 IE 34877B1 IE 421/70 A IE421/70 A IE 421/70A IE 42170 A IE42170 A IE 42170A IE 34877 B1 IE34877 B1 IE 34877B1
Authority
IE
Ireland
Prior art keywords
alkyl
compound
substituted
triazine
methyl
Prior art date
Application number
IE421/70A
Other versions
IE34877L (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IE34877B1 publication Critical patent/IE34877B1/en
Publication of IE34877L publication Critical patent/IE34877L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/54Three nitrogen atoms
    • C07D251/70Other substituted melamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1308811 s-Triazine derivatives AMERICAN CYANAMID CO 22 May 1970 [22 May 1969 (3)] 24974/70 Heading C2C [Also in Division A5] Novel compounds of Formulµ (a) to (f) wherein R 1 is (C 1 -C 8 ) n-alkyl, (C 4 -C 8 ) secalkyl, (C 4 -C 11 ) tert-alkyl, (C 3 -C 8 ) cycloalkyl or methyl-substituted (C 3 -C 8 ) cycloalkyl; each of R 2 and R 3 is individually (C 4 -C 8 ) sec-alkyl, (C 4 -C 11 ) tert-alkyl, (C 3 -C 8 ) cycloalkyl or methyl-substituted (C 3 -C 8 ) cycloalkyl; R 4 is adamantyl or bicyclo [2.2.1]heptyl; each of R 5 and R 6 is individually (C 1 -C 8 ) n-alkyl, (C 4 -C 8 ) sec-alkyl, (C 4 -C 11 ) tert-alkyl, (C 3 -C 8 ) cycloalkyl, methyl-substituted (C 3 -C 8 ) cycloalkyl, adamantyl, bicyclo [2.2.1]heptyl or methylsubstituted bicyclo [2.2.1]heptyl; R 7 is (C 4 - C 11 ) tert-alkyl, adamantyl, methyl-substituted adamantyl, bicyclo [2.2.1]heptyl or methyl substituted bicyclo [2.2.1]heptyl; R 8 is (C 4 - C 8 ) sec-alkyl, (C 4 -C 11 ) tert-alkyl, (C 3 -C 8 ) cyclo- alkyl, methyl-substituted (C 3 -C 8 ) cycloalkyl, adamantyl, methyl substituted adamantyl, bicyclo [2.2.1]heptyl or methyl-substituted bicyclo [2.2.1]heptyl; each of (R 9 and R 10 ) and (R 11 and R 12 ) are taken together with the nitrogen atom to which they are attached in each instance to form a polymethylene-imino group of from 4 to 6 carbon atoms substituted with from 0 to 4 methyl groups; R 13 is (C 1 -C 8 ) nalkyl, (C 4 -C 8 ) sec-alkyl, (C 3 -C 8 ) cycloalkyl or methyl substituted (C 3 -C 8 ) cycloalkyl; R 14 is (C 1 -C 8 ) n-alkyl or sec-alkyl; and R 15 is methyl substituted adamantyl provided that R 1 , R 2 and R 3 are not identical representing t-butyl, cyclohexyl or 2,4,4-trimethyl-2-pentyl-; or a non- toxic pharmaceutically acceptable salt thereof, are prepared by one of the following methods, (a) a compound of formula wherein each Z is individually chloro, bromo, fluoro, iodo, hydroxyl,-O-alkyl,-O-phenyl, -SH, -S-alkyl, -SO-alkyl, -SO 2 -alkyl- N 3 , -C#N, -N<SP>+</SP>(CH 3 ) 3 , -NH 2 , trichloroalkyl, trifluoroalkyl, guanidino, R-substituted guanidino, NHR or NRR; not more than two of the Z substituents being -NHR and/or -NRR; with a compound of the formula wherein X is -NH 2 , -CO-R, -CHO, -CR=CR, -NHY wherein Y is -CN, -NH 2 , -OH, acyl, sulphonyl, Si(CH 3 ) 3 or a negative charge; -Cl, -Br; F, -I, -OH, -O-alkyl, -O-phenyl, -SH, -S-alkyl, -SO-alkyl, -SO 2 -alkyl, -N 3 , -C#N, -N<SP>+</SP>(CH 3 ) 3 , -NH 2 , -NHR or -NRR; at least one of X and Z containing nitrogen, with the proviso that when X is the same group as Z, X and Z are either -NH 2 or -NHR; R in each case above being selected from R 1 to R 15 such that the compound produced by the reaction is a compound within any one of the Formulµ (a) to (f) above, or when X is -CO-R or CHO, the compound produced by the reaction is reducible to a compound within any one of the Formulµ (a) to (f) above; in the presence or absence of a Lewis acid catalyst in a stepwise manner when the R-substituents on the compound to be produced are different, or in a stepwise and/or concurrent manner when the R- substituents on the compound to be produced are the same; and when X is -CO-R or -CHO, reducing the resulting compound to a compound within any one of the Formulµ (a) to (f) above; (b) when the desired product is a tris-(alkyl-substituted amino)-s-triazine it may be prepared by trimerizing by heat treatment with alkali, a compound of the formula R-C#N; or (c) by reacting a compound of formula wherein Z is defined above, n is 1, 2 or 3 and A and B are chemical valencies which, when taken together form a single bond, or may be bonded to other atoms in a symmetrically or unsymmetrically substituted dimeric or trimeric open chain, with a compound of the formula wherein R and X are each as defined above and the selection of R, X and Z being subject to the same provisos as laid out hereinabove; in the presence or absence of a Lewis acid catalyst, and thereafter, or concurrently, cyclizing the compound produced, or being produced and, when the compound produced is in the form of an iso melamine, isomerizing the isomelamine into an s-triazine of any one of the Formulµ (a) to (f) by treatment with a base. Intermediates isolated in the above processes as exemplified are: 2,4-dichloro-6-(2,2,6,6-tetramethyl - 1 - piperidino) - s - triazine, 6 - chloro- 2,4 - biscyclohexylamino - s - triazine, 2- chloro - 4,6 - bis - (2,3,3 - trimethyl - 2 - butylamino) - s - triazine, 2 - cyano - 4,6 - bis - (2,4,4- trimethyl - 2 - pentylamino) - s - triazine, 2,4- bis - (N - acetyl - 2,4,4 - trimethyl - 2 - pentylamino) - 6 - (2,4,4 - trimethyl - 2 - pentylamino)- s - triazine, 2 - chloro - bis - (tert - pentylamino) - s - triazine, 2 - phenoxy - bis - (tertpentylamino) - s - triazine, 2 - methoxy - bis- (2,4,4 - trimethyl - 2 - pentylamino) - s - triazine and 2 - methylthio - 4,6 - bis - (2,4,4 - trimethyl- 2-pentylamino)-s-triazine. Reference has been directed by the Comptroller to Specification 1,013,223. [GB1308811A]
IE700421A 1969-05-22 1970-04-03 s-TRIAZINES IE34877L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82704869A 1969-05-22 1969-05-22
US82703169A 1969-05-22 1969-05-22
US82703269A 1969-05-22 1969-05-22

Publications (2)

Publication Number Publication Date
IE34877B1 true IE34877B1 (en) 1975-09-17
IE34877L IE34877L (en) 1975-09-17

Family

ID=27420190

Family Applications (1)

Application Number Title Priority Date Filing Date
IE700421A IE34877L (en) 1969-05-22 1970-04-03 s-TRIAZINES

Country Status (17)

Country Link
JP (2) JPS4839945B1 (en)
AT (1) AT306041B (en)
BG (1) BG20376A3 (en)
BR (1) BR6915234D0 (en)
CH (1) CH549589A (en)
CS (2) CS167921B2 (en)
DE (1) DE2025080A1 (en)
FR (1) FR2051553B1 (en)
GB (1) GB1308811A (en)
HU (1) HU164355B (en)
IE (1) IE34877L (en)
IL (1) IL34286A (en)
NL (1) NL7007103A (en)
NO (1) NO128224B (en)
OA (1) OA04242A (en)
RO (1) RO57534A (en)
ZM (1) ZM4370A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA791262B (en) * 1978-04-12 1980-07-30 American Cyanamid Co Novel anti-arthritic 2,4,6-tris.(substituted-amino)-striazines
JPS576367A (en) * 1980-06-12 1982-01-13 Chubu Electric Power Co Inc Method for detecting partial discharge of power cable
JPS5991376A (en) * 1982-11-16 1984-05-26 Kansai Electric Power Co Inc:The Diagnosis of deterioration in insulation of power cable
DE3611427A1 (en) * 1986-04-05 1987-10-08 Hoechst Ag BIS-TERTIAERBUTYLAMINO-SUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND THEIR USE
JPS62155323A (en) * 1986-12-27 1987-07-10 Nippon Seiko Kk Dynamic pressure type composite bearing device
JPS63150914U (en) * 1987-03-24 1988-10-04
AT389303B (en) * 1987-10-08 1989-11-27 Hoechst Ag Novel bis-tertiary-butylamino-substituted 1,3,5-triazine derivatives, process for their preparation, medicaments containing these compounds, and their use
AU621082B2 (en) * 1988-02-08 1992-03-05 Ciba-Geigy Ag Tetramethylpiperidino-s-triazines
AR036375A1 (en) 2001-08-30 2004-09-01 Novartis Ag PIRROLO [2,3-D] PIRIMIDINE -2- CARBONITRILE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF MEDICINES
SE0201976D0 (en) * 2002-06-24 2002-06-24 Astrazeneca Ab Novel compounds
EP2197858B1 (en) * 2007-08-31 2014-07-02 HanAll Biopharma Co., Ltd. 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691021A (en) * 1954-10-05 Trimerization of t

Also Published As

Publication number Publication date
OA04242A (en) 1979-12-31
DE2025080A1 (en) 1970-11-26
CS167922B2 (en) 1976-05-28
FR2051553B1 (en) 1976-04-16
ZM4370A1 (en) 1971-02-22
CH549589A (en) 1974-05-31
BR6915234D0 (en) 1973-06-07
NO128224B (en) 1973-10-15
JPS4839945B1 (en) 1973-11-28
BG20376A3 (en) 1975-11-05
CS167921B2 (en) 1976-05-28
FR2051553A1 (en) 1971-04-09
HU164355B (en) 1974-02-28
NL7007103A (en) 1970-11-24
AT306041B (en) 1973-03-26
IL34286A (en) 1974-03-14
JPS4917272B1 (en) 1974-04-27
GB1308811A (en) 1973-03-07
RO57534A (en) 1975-01-15
IE34877L (en) 1975-09-17
IL34286A0 (en) 1970-12-24

Similar Documents

Publication Publication Date Title
IE34877B1 (en) Triazine-derivatives
US20020115668A1 (en) Trisubstituted 1,3,5-triazine derivatives
US2566231A (en) Preparation of melamine
DE3587717T2 (en) N-6-thienyl-substituted adenosine derivatives as cardiovascular agents.
EP0945446A4 (en) Cyanoethylmelamine derivatives and process for producing the same
US2394042A (en) Triazine derivatives
US4287338A (en) Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
DE3465307D1 (en) Condensed n-phenylsulfonyl-n&#39;-pyrimidinyl and triazinyl urea
US3154547A (en) Process for preparing 2-amino-s-triazines
Smyrl et al. Hydroxide‐catalyzed synthesis of heterocyclic aromatic amine derivatives from nitriles
US2455396A (en) Organic nitrogen compounds and methods for obtaining same
US3830810A (en) S-triazine derivatives
GB1132306A (en) s-triazine plant growth regulating agents
US3101335A (en) Diureidotriazines and process for making
US2976288A (en) Triazine derivatives
US3873544A (en) Cyanoalkylamino-s-triazines
US2295565A (en) Triazine derivatives
KR930002347A (en) Cycloalkyltriols containing cyclic substituents, methods for their preparation, intermediate products in their preparation, and their use as antiviral and antiparasitic agents
ES379873A1 (en) 2,4,6-trisubstituted-s-triazines
US2658893A (en) Preparation of halodiaminotriazines
US2217030A (en) Substituted triazines
US2328958A (en) Triazine derivatives
Bredereck et al. Syntheses of s‐Triazine and Substituted s‐Triazines
US2797225A (en) 1, 3, 4-thiadiazolyl-nu-acylsulfonamides
Simig et al. On the occurrence of the SN (ANRORC) mechanism in the amination of substituted 1, 3, 5‐triazines